MENU
+Compare
STAA
Stock ticker: NASDAQ
AS OF
Dec 3 closing price
Price
$26.37
Change
+$0.45 (+1.74%)
Capitalization
1.3B

STAA STAAR Surgical Company Forecast, Technical & Fundamental Analysis

Staar Surgical Co is a manufacturer of lenses... Show more

STAA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for STAA with price predictions
Nov 28, 2025

STAA in +5.86% Uptrend, advancing for three consecutive days on November 21, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where STAA advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on November 26, 2025. You may want to consider a long position or call options on STAA as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

STAA moved above its 50-day moving average on November 28, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for STAA crossed bullishly above the 50-day moving average on November 26, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 190 cases where STAA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for STAA turned negative on November 26, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STAA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. STAA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.679) is normal, around the industry mean (9.233). P/E Ratio (49.727) is within average values for comparable stocks, (163.343). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.548). STAA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (5.653) is also within normal values, averaging (110.831).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STAA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
STAA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

STAA is expected to report earnings to fall 48.78% to 9 cents per share on February 25

STAAR Surgical Company STAA Stock Earnings Reports
Q4'25
Est.
$0.09
Q3'25
Est.
$0.18
Q2'25
Beat
by $0.22
Q1'25
Missed
by $0.52
Q4'24
Missed
by $0.66
The last earnings report on November 05 showed earnings per share of 18 cents, meeting the estimate of 18 cents. With 692.48K shares outstanding, the current market capitalization sits at 1.30B.
A.I. Advisor
published General Information

General Information

a designer of implantable lenses for the eye and delivery systems used to deliver lenses into the eye

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
25651 Atlantic Ocean Drive
Phone
+1 626 303-7902
Employees
1115
Web
https://www.staar.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCEQX104.29N/A
N/A
Green Century Equity Individual Investor
PCVCX9.73N/A
N/A
Virtus NFJ Small-Cap Value C
MSFAX33.45N/A
N/A
Morgan Stanley Inst Global Franchise I
JEMOX41.25N/A
N/A
JPMorgan Emerging Markets Equity R5
QNTIX40.89N/A
N/A
Meeder Sector Rotation Institutional

STAA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, STAA has been loosely correlated with XRAY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if STAA jumps, then XRAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STAA
1D Price
Change %
STAA100%
+0.04%
XRAY - STAA
53%
Loosely correlated
-0.67%
WST - STAA
44%
Loosely correlated
-0.39%
OFIX - STAA
38%
Loosely correlated
-0.69%
CSTL - STAA
38%
Loosely correlated
-0.03%
IQV - STAA
37%
Loosely correlated
-1.23%
More

Groups containing STAA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STAA
1D Price
Change %
STAA100%
+0.04%
Pharmaceuticals
category (377 stocks)
26%
Poorly correlated
+0.67%
Pharmaceuticals: Other
category (103 stocks)
23%
Poorly correlated
+0.77%